Physician

Carl Sylvester Wehri, MD

According to 2025 Medicare claims, Carl Wehri, MD (NPI: 1669537791) practices family practice in the Lima, OH market, with the plurality of this provider's patient population coming from Allen, OH. This provider's primary affiliated billing organization is DELPHOS FAMILY PHYSICIANS INC (NPI: 1841261476; TIN: 341271245) and primary practice location at 45833-9141.

Wehri's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 161 traditional Medicare patients, billed 6,061 HCPCS/CPT codes, and received $162,027 in Medicare payments. The top billing code was 80061 (Blood test, lipids (cholesterol and triglycerides)). Part D data shows 4,715 prescription claims across 211 beneficiaries totaling $645,760 in drug costs, led by Eliquis (Apixaban). DME data shows 189 claims. Open Payments data shows 77 records totaling $1,247. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $3,101 to $16,149.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	186	8,880	$179,753
2016	195	9,656	$186,879
2017	198	9,221	$183,280
2018	186	8,425	$174,251
2019	175	7,703	$148,032
2020	176	6,689	$120,348
2021	243	7,879	$154,301
2022	177	7,242	$138,471
2023	163	6,333	$148,283
2024	161	6,061	$162,027

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	216	5,813	$540,138
2016	217	5,546	$532,744
2017	219	5,342	$466,035
2018	221	5,536	$474,968
2019	212	5,085	$479,618
2020	225	5,117	$511,851
2021	228	5,152	$546,635
2022	219	4,793	$534,965
2023	212	4,706	$566,507
2024	211	4,715	$645,760

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	29	137	$3,863
2016	25	150	$3,303
2017	22	143	$2,359
2018	18	96	$2,063
2019	12	71	$1,624
2020	12	67	$2,445
2021	12	77	$3,085
2022	N/R	77	$4,708
2023	N/R	15	$3,294
2024	N/R	189	$29,381

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
80061	Blood test, lipids (cholesterol and triglycerides)	137	229	$13
83721	Ldl cholesterol level	142	360	$10
83036	Hemoglobin a1c level	134	258	$9
36415	Insertion of needle into vein for collection of blood sample	143	467	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	135	275	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	75	4,296	$75,758
Otezla	Apremilast	13	390	$57,720
Jardiance	Empagliflozin	37	2,566	$45,313
Ozempic	Semaglutide	25	1,206	$37,319
Trulicity	Dulaglutide	16	1,084	$33,694

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4353	Intermittent urinary catheter, with insertion supplies	N	N/R	11	$14,809
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	14	$7,391
A4409	Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, without built-in convexity, 4 x 4 inches or smaller, each	N	N/R	11	$1,456
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	20	$1,399
A4411	Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, with built-in convexity, each	N	N/R	11	$1,083

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	77	$1,247	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Carl Sylvester Wehri, MD?

Tedicare shows public-source Medicare data for Carl Sylvester Wehri, MD (NPI 1669537791), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carl Sylvester Wehri, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Carl Sylvester Wehri, MD?

Carl Sylvester Wehri, MD is linked to DELPHOS FAMILY PHYSICIANS INC (billing NPI 1841261476) in the available physician profile data.

Does Carl Sylvester Wehri, MD have Open Payments data?

Carl Sylvester Wehri, MD has 77 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.